Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1983-01-26
1985-07-09
Roberts, Elbert L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
A01N 3702
Patent
active
045281971
ABSTRACT:
Method and composition for enhancing protein anabolism in an hypercatabolic mammal. The method comprises parenterally administering to the mammal nutritionally sufficient sources for amino acids, carbohydrates and lipids, the lipids comprising a controlled triglyceride source which, on hydrolysis, yields both long chain fatty acids and medium chain fatty acids, preferably about 20 to 80% long chain fatty acids and about 80 to 20% medium chain fatty acids. In one embodiment, the composition has the additional benefit of being capable of providing more than 60% of the total caloric requirements of the mammal via the lipid source without immunological impairment of the reticuloendothelial system of the mammal.
REFERENCES:
patent: 4272548 (1981-06-01), Gatzen et al.
patent: 4330557 (1982-05-01), Cavazza
patent: 4401657 (1983-08-01), Kashiwabara et al.
patent: 4414238 (1983-11-01), Schmidt
V. K. Babayan, "Medium Chain Length Fatty Acid Esters and Their Medical and Nutritional Applications", JAOCS, Jan., 1981, pp. 49A-51A.
Kabivitrum AB
Roberts Elbert L.
LandOfFree
Controlled triglyceride nutrition for hypercatabolic mammals does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Controlled triglyceride nutrition for hypercatabolic mammals, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled triglyceride nutrition for hypercatabolic mammals will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-908883